Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Vanta Bioscience Financial Results

Vanta Bioscience Limited approved audited standalone and consolidated financial results for FY2026. The board also re-appointed Mr. Dopesh Raja Mulakala as Managing Director for three years.

Source

BSE filing, NSE: VANTA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vanta Bioscience Ltd: key numbers

Share price
₹20.39
Market cap
₹14.50 Cr
Revenue (annual)
₹1.82 Cr
Net profit (annual)
₹0.11 Cr
P/E (TTM)
133.9×Sector 33.4×
Promoter holding
72.81%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vanta Bioscience Ltd

All →

Other financial results announcements

All →
21:34 IST BSE
Financial ResultsChemkart India Ltd 544442

Chemkart India H1 FY27 Results: Net Profit ₹22.6 Cr, Up 121.6% YoY

Chemkart India Ltd reported revenue from operations of ₹205.9 Cr (+99.5% YoY) and net profit of ₹22.6 Cr (+121.6% YoY) for H1 FY27.

Key figure
Net profit ₹22.6 Cr · +121.6% YoY